24時間365日サポート — いつでもお客様をサポートいたします。
お問い合わせ
Fish Vaccine Market – Global Industry Analysis And Growth
The Fish Vaccine Market is expected to go niche to offer vaccinations for fish species against diseases resulting from bacteria, viruses and parasite. These vaccines are vital in fish farming to boost fish health, reduce mortality rate thereby improving yields and new solutions provided to the fish farming market. Vaccination of fishes prevent outbreak of diseases and so prevent the use of antibiotics and chemicals that have capability of polluting the environment in fish farming.
IMR
Description
Fish Vaccine Market Synopsis
Fish Vaccine Market Size is Valued at USD 408.20 Million in 2023, and is Projected to Reach USD 706.64 Million by 2032, Growing at a CAGR of 7.10% From 2024-2032.
The Fish Vaccine Market is expected to go niche to offer vaccinations for fish species against diseases resulting from bacteria, viruses and parasite. These vaccines are vital in fish farming to boost fish health, reduce mortality rate thereby improving yields and new solutions provided to the fish farming market. Vaccination of fishes prevent outbreak of diseases and so prevent the use of antibiotics and chemicals that have capability of polluting the environment in fish farming.
Another attractive force in the Fish Vaccine Market is the increased consumption of fish due to the global trend for developing environmentally friendly methods of cattle breeding. This is especially so given ever increasing global consumption of fish products among which Asia-Pacific and European markets stand out most prominently; aquaculture has thus emerged as a strategic sub-sector in addressing FOOD security. Fish diseases also pose negative impacts in the fish industries, so vaccines provide a solution to the problem. As a result, the use of vaccines to protect fish stock and keep aquaculture production on track has gained larger popularity.
Further, rising technological growth in vaccines especially the flu vaccine has also been a driver to the market. This has spurred vaccines improvements making recombinant and DNA vaccines to become efficient and safe. These have further empowered the farmers to guard fish against numerous pathogens in a more efficient way hence cutting down the common use of antibiotics and other chemicals. Recognizing the importance of controlling antibiotic resistance while fishery authorities and industries address the issues, vaccines for fish are gradually becoming a crucial instrument for achieving a healthier and more effective aquaculture industry.
Fish Vaccine Market Trend Analysis
Growing focus on biosecurity measures in aquaculture farms
Another important trend that defines development of Fish Vaccine Market is the increased concern on biosecurity measures of aquaculture farms. With development of aquaculture as one of the fastest growing sectors of the global animal food production system, there is increasing concern over the management of diseases. Incorporation of fish vaccines is gradually becoming an important piece of the biosecurity armoury as such vaccines can provide sustainable forms of immunity against standard diseases. Furthermore, there is a focus on having wider coverage vaccines that is, the multiple vaccinations offering different types could be administered at once thereby making the process more efficient on the farm.
Another trend is an increase in Oral and immersion vaccines because they use simplified methods of administration which do not need any form of needle injection processes. Such new approaches of the vaccines are gradually being adopted in the aquaculture farms, especially those managing huge number of fish. This has the advantage of easy administration since it goes along with feed and does not cause stress on fish as is with oral vaccines. Personally, this development is somewhat a boon especially for the small-scale farmers who cannot afford the time or money to carry out elaborate vaccination processes.
Fish species are exposed to different pathogens, creating a demand for new and effective vaccines.
Undoubtedly there is tremendous potential in the production of vaccines for new forms of fish diseases. As have been seen and experienced, aquaculture moves to new areas with different characteristics, fish species are exposed to new pathogens’ infection thereby raising the need to develop new vaccines. Business people that can discover essays targeting these developing diseases will be strategic. Also, scientific advancements in developing less-expensive technologies to produce vaccines, such a plant-based or synthetic, remain as potential sources of new growth.
It also opens the door for increasing fish vaccination in the developing nations where aquaculture is comparatively new but is growing swiftly and remains quite sensitive to disease threats. These opportunities are crucial for the governments of these regions that aim at boosting food security and stabilising economies through aquaculture, as well as for local fish producers who can find new strategic partners in the global vaccine producers. More awareness about the fish vaccination could however be achieved through promotional education and awareness on how essential the program is.
Fish Vaccine Market Segment Analysis:
Fish Vaccine Market Segmented on the basis of type, By Fish Type, By Route of Administration, application, and end-users.
By Type, Live Attenuated Vaccines segment is expected to dominate the market during the forecast period
Fish vaccines can also be categorised into several forms depending on the method employed in preparation. Live attenuated vaccines use strains of the pathogen that are less virulent and are able contact tissues an stimulate an immune response. There are other types of vaccines, some of the inactivated one contain killed pathogens which cannot reproduce, but they stimulate antibodies production. Recombinant vaccines are genetic engineered vaccines which comprises of certain proteins of the pathogen.it helps in the creation of immunity against a particular disease. The DNA vaccines work through the transfection of genetic informa- tion from the pathogen into fish cells with the intention of inciting an immune response. Subunit vaccines, on the other hand, employ all or elements of the pathogen and specifically may use proteins, that trigger only protective immune response of the body. The above various types of vaccines offer distinct arrangements of disease prevention in aquaculture.
By Application, Viral Infections segment held the largest share in 2023
Fish vaccines can also be classified depending on the site of application concerning the intended type of infection. Vaccines against bacterial infections are intended to prevent fish against different pathogenic bacteria that cause the diseases, including the vibriosis and columnar is disease. Some of the vaccines assist in decreasing mortality levels and enhancing healthy fry in the farming practices in aquaculture. The other type is produced for viral infection diseases that are diseases caused by virus including the infectious pancreatic necrosis (IPN) and the viral hemorrhagic septicaemia (VHS). These vaccines have a big importance in the fish health especially because levels densities of fish farming are highly increased. Finally, vaccines for parasitic diseases are used to treat diseases spreading because of parasites and these include sea lice and other external/ internal parasites. Since the mentioned specific application, fish vaccines play an important part in the welfare and yield of fish in aquaculture.
Fish Vaccine Market Regional Insights:
Europe is Expected to Dominate the Market Over the Forecast period
Europe is the largest consumer in the Fish Vaccine Market since the continent has a highly developed aquaculture sector as well as adaptive and strict legislation regarding sustainable usage. Norway and Scotland are the leading producers of fish farming, especially of salmon that ranks high on the list of species that have benefited from improved vaccination methods. Europe’s efforts to cut antibiotic use in fish farming has aggravated the fish vaccine demand, making Europe the world’s largest fish vaccine market.
Also, Europe’s highly regulated and authoritarian animal welfare and food safety policies fuels the demand for fish vaccines. The region has one of the most developed aquaculture industries, ever increasing numbers of fish farmers are relying on vaccines rather than chemicals to treat disease. Along with regulatory support, technological advancement, Europe is the leading market in Fish Vaccine Market.
Active Key Players in the Fish Vaccine Market
Merck Animal Health (United States)
Zoetis Inc. (United States)
Elanco Animal Health (United States)
Phibro Animal Health Corporation (United States)
HIPRA (Spain)
Virbac (France)
Kyoritsu Seiyaku Corporation (Japan)
Tecnovax (Argentina)
Veterquimica S.A. (Chile)
FishVet Group (United Kingdom)
Others
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Fish Vaccine Market by Type (2018-2032)
4.1 Fish Vaccine Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Live Attenuated Vaccines
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Inactivated Vaccines
4.5 Recombinant Vaccines
4.6 DNA Vaccines
4.7 Subunit Vaccines
Chapter 5: Fish Vaccine Market by Fish Type (2018-2032)
5.1 Fish Vaccine Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Salmon
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Tilapia
5.5 Trout
5.6 Carp
5.7 Catfish
5.8 Sea Bass
5.9 Others
Chapter 6: Fish Vaccine Market by Route of Administration (2018-2032)
6.1 Fish Vaccine Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Injection Vaccines
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Oral Vaccines
6.5 Immersion Vaccines
Chapter 7: Fish Vaccine Market by Application (2018-2032)
7.1 Fish Vaccine Market Snapshot and Growth Engine
7.2 Market Overview
7.3 Bacterial Infections
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
7.3.3 Key Market Trends, Growth Factors, and Opportunities
7.3.4 Geographic Segmentation Analysis
7.4 Viral Infections
7.5 Parasitic Infections
Chapter 8: Fish Vaccine Market by End User (2018-2032)
8.1 Fish Vaccine Market Snapshot and Growth Engine
8.2 Market Overview
8.3 Aquaculture Farms
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
8.3.3 Key Market Trends, Growth Factors, and Opportunities
8.3.4 Geographic Segmentation Analysis
8.4 Veterinary Clinics
8.5 Research Institutes
Chapter 9: Company Profiles and Competitive Analysis
9.1 Competitive Landscape
9.1.1 Competitive Benchmarking
9.1.2 Fish Vaccine Market Share by Manufacturer (2024)
9.1.3 Industry BCG Matrix
9.1.4 Heat Map Analysis
9.1.5 Mergers and Acquisitions
9.2 MERCK ANIMAL HEALTH (UNITED STATES)
9.2.1 Company Overview
9.2.2 Key Executives
9.2.3 Company Snapshot
9.2.4 Role of the Company in the Market
9.2.5 Sustainability and Social Responsibility
9.2.6 Operating Business Segments
9.2.7 Product Portfolio
9.2.8 Business Performance
9.2.9 Key Strategic Moves and Recent Developments
9.2.10 SWOT Analysis
9.3 ZOETIS INC. (UNITED STATES)
9.4 ELANCO ANIMAL HEALTH (UNITED STATES)
9.5 PHIBRO ANIMAL HEALTH CORPORATION (UNITED STATES)
9.6 HIPRA (SPAIN)
9.7 VIRBAC (FRANCE)
9.8 KYORITSU SEIYAKU CORPORATION (JAPAN)
9.9 TECNOVAX (ARGENTINA)
9.10 VETERQUIMICA S.A. (CHILE)
9.11 FISHVET GROUP (UNITED KINGDOM)
9.12 OTHERS
9.13
Chapter 10: Global Fish Vaccine Market By Region
10.1 Overview
10.2. North America Fish Vaccine Market
10.2.1 Key Market Trends, Growth Factors and Opportunities
10.2.2 Top Key Companies
10.2.3 Historic and Forecasted Market Size by Segments
10.2.4 Historic and Forecasted Market Size by Type
10.2.4.1 Live Attenuated Vaccines
10.2.4.2 Inactivated Vaccines
10.2.4.3 Recombinant Vaccines
10.2.4.4 DNA Vaccines
10.2.4.5 Subunit Vaccines
10.2.5 Historic and Forecasted Market Size by Fish Type
10.2.5.1 Salmon
10.2.5.2 Tilapia
10.2.5.3 Trout
10.2.5.4 Carp
10.2.5.5 Catfish
10.2.5.6 Sea Bass
10.2.5.7 Others
10.2.6 Historic and Forecasted Market Size by Route of Administration
10.2.6.1 Injection Vaccines
10.2.6.2 Oral Vaccines
10.2.6.3 Immersion Vaccines
10.2.7 Historic and Forecasted Market Size by Application
10.2.7.1 Bacterial Infections
10.2.7.2 Viral Infections
10.2.7.3 Parasitic Infections
10.2.8 Historic and Forecasted Market Size by End User
10.2.8.1 Aquaculture Farms
10.2.8.2 Veterinary Clinics
10.2.8.3 Research Institutes
10.2.9 Historic and Forecast Market Size by Country
10.2.9.1 US
10.2.9.2 Canada
10.2.9.3 Mexico
10.3. Eastern Europe Fish Vaccine Market
10.3.1 Key Market Trends, Growth Factors and Opportunities
10.3.2 Top Key Companies
10.3.3 Historic and Forecasted Market Size by Segments
10.3.4 Historic and Forecasted Market Size by Type
10.3.4.1 Live Attenuated Vaccines
10.3.4.2 Inactivated Vaccines
10.3.4.3 Recombinant Vaccines
10.3.4.4 DNA Vaccines
10.3.4.5 Subunit Vaccines
10.3.5 Historic and Forecasted Market Size by Fish Type
10.3.5.1 Salmon
10.3.5.2 Tilapia
10.3.5.3 Trout
10.3.5.4 Carp
10.3.5.5 Catfish
10.3.5.6 Sea Bass
10.3.5.7 Others
10.3.6 Historic and Forecasted Market Size by Route of Administration
10.3.6.1 Injection Vaccines
10.3.6.2 Oral Vaccines
10.3.6.3 Immersion Vaccines
10.3.7 Historic and Forecasted Market Size by Application
10.3.7.1 Bacterial Infections
10.3.7.2 Viral Infections
10.3.7.3 Parasitic Infections
10.3.8 Historic and Forecasted Market Size by End User
10.3.8.1 Aquaculture Farms
10.3.8.2 Veterinary Clinics
10.3.8.3 Research Institutes
10.3.9 Historic and Forecast Market Size by Country
10.3.9.1 Russia
10.3.9.2 Bulgaria
10.3.9.3 The Czech Republic
10.3.9.4 Hungary
10.3.9.5 Poland
10.3.9.6 Romania
10.3.9.7 Rest of Eastern Europe
10.4. Western Europe Fish Vaccine Market
10.4.1 Key Market Trends, Growth Factors and Opportunities
10.4.2 Top Key Companies
10.4.3 Historic and Forecasted Market Size by Segments
10.4.4 Historic and Forecasted Market Size by Type
10.4.4.1 Live Attenuated Vaccines
10.4.4.2 Inactivated Vaccines
10.4.4.3 Recombinant Vaccines
10.4.4.4 DNA Vaccines
10.4.4.5 Subunit Vaccines
10.4.5 Historic and Forecasted Market Size by Fish Type
10.4.5.1 Salmon
10.4.5.2 Tilapia
10.4.5.3 Trout
10.4.5.4 Carp
10.4.5.5 Catfish
10.4.5.6 Sea Bass
10.4.5.7 Others
10.4.6 Historic and Forecasted Market Size by Route of Administration
10.4.6.1 Injection Vaccines
10.4.6.2 Oral Vaccines
10.4.6.3 Immersion Vaccines
10.4.7 Historic and Forecasted Market Size by Application
10.4.7.1 Bacterial Infections
10.4.7.2 Viral Infections
10.4.7.3 Parasitic Infections
10.4.8 Historic and Forecasted Market Size by End User
10.4.8.1 Aquaculture Farms
10.4.8.2 Veterinary Clinics
10.4.8.3 Research Institutes
10.4.9 Historic and Forecast Market Size by Country
10.4.9.1 Germany
10.4.9.2 UK
10.4.9.3 France
10.4.9.4 The Netherlands
10.4.9.5 Italy
10.4.9.6 Spain
10.4.9.7 Rest of Western Europe
10.5. Asia Pacific Fish Vaccine Market
10.5.1 Key Market Trends, Growth Factors and Opportunities
10.5.2 Top Key Companies
10.5.3 Historic and Forecasted Market Size by Segments
10.5.4 Historic and Forecasted Market Size by Type
10.5.4.1 Live Attenuated Vaccines
10.5.4.2 Inactivated Vaccines
10.5.4.3 Recombinant Vaccines
10.5.4.4 DNA Vaccines
10.5.4.5 Subunit Vaccines
10.5.5 Historic and Forecasted Market Size by Fish Type
10.5.5.1 Salmon
10.5.5.2 Tilapia
10.5.5.3 Trout
10.5.5.4 Carp
10.5.5.5 Catfish
10.5.5.6 Sea Bass
10.5.5.7 Others
10.5.6 Historic and Forecasted Market Size by Route of Administration
10.5.6.1 Injection Vaccines
10.5.6.2 Oral Vaccines
10.5.6.3 Immersion Vaccines
10.5.7 Historic and Forecasted Market Size by Application
10.5.7.1 Bacterial Infections
10.5.7.2 Viral Infections
10.5.7.3 Parasitic Infections
10.5.8 Historic and Forecasted Market Size by End User
10.5.8.1 Aquaculture Farms
10.5.8.2 Veterinary Clinics
10.5.8.3 Research Institutes
10.5.9 Historic and Forecast Market Size by Country
10.5.9.1 China
10.5.9.2 India
10.5.9.3 Japan
10.5.9.4 South Korea
10.5.9.5 Malaysia
10.5.9.6 Thailand
10.5.9.7 Vietnam
10.5.9.8 The Philippines
10.5.9.9 Australia
10.5.9.10 New Zealand
10.5.9.11 Rest of APAC
10.6. Middle East & Africa Fish Vaccine Market
10.6.1 Key Market Trends, Growth Factors and Opportunities
10.6.2 Top Key Companies
10.6.3 Historic and Forecasted Market Size by Segments
10.6.4 Historic and Forecasted Market Size by Type
10.6.4.1 Live Attenuated Vaccines
10.6.4.2 Inactivated Vaccines
10.6.4.3 Recombinant Vaccines
10.6.4.4 DNA Vaccines
10.6.4.5 Subunit Vaccines
10.6.5 Historic and Forecasted Market Size by Fish Type
10.6.5.1 Salmon
10.6.5.2 Tilapia
10.6.5.3 Trout
10.6.5.4 Carp
10.6.5.5 Catfish
10.6.5.6 Sea Bass
10.6.5.7 Others
10.6.6 Historic and Forecasted Market Size by Route of Administration
10.6.6.1 Injection Vaccines
10.6.6.2 Oral Vaccines
10.6.6.3 Immersion Vaccines
10.6.7 Historic and Forecasted Market Size by Application
10.6.7.1 Bacterial Infections
10.6.7.2 Viral Infections
10.6.7.3 Parasitic Infections
10.6.8 Historic and Forecasted Market Size by End User
10.6.8.1 Aquaculture Farms
10.6.8.2 Veterinary Clinics
10.6.8.3 Research Institutes
10.6.9 Historic and Forecast Market Size by Country
10.6.9.1 Turkiye
10.6.9.2 Bahrain
10.6.9.3 Kuwait
10.6.9.4 Saudi Arabia
10.6.9.5 Qatar
10.6.9.6 UAE
10.6.9.7 Israel
10.6.9.8 South Africa
10.7. South America Fish Vaccine Market
10.7.1 Key Market Trends, Growth Factors and Opportunities
10.7.2 Top Key Companies
10.7.3 Historic and Forecasted Market Size by Segments
10.7.4 Historic and Forecasted Market Size by Type
10.7.4.1 Live Attenuated Vaccines
10.7.4.2 Inactivated Vaccines
10.7.4.3 Recombinant Vaccines
10.7.4.4 DNA Vaccines
10.7.4.5 Subunit Vaccines
10.7.5 Historic and Forecasted Market Size by Fish Type
10.7.5.1 Salmon
10.7.5.2 Tilapia
10.7.5.3 Trout
10.7.5.4 Carp
10.7.5.5 Catfish
10.7.5.6 Sea Bass
10.7.5.7 Others
10.7.6 Historic and Forecasted Market Size by Route of Administration
10.7.6.1 Injection Vaccines
10.7.6.2 Oral Vaccines
10.7.6.3 Immersion Vaccines
10.7.7 Historic and Forecasted Market Size by Application
10.7.7.1 Bacterial Infections
10.7.7.2 Viral Infections
10.7.7.3 Parasitic Infections
10.7.8 Historic and Forecasted Market Size by End User
10.7.8.1 Aquaculture Farms
10.7.8.2 Veterinary Clinics
10.7.8.3 Research Institutes
10.7.9 Historic and Forecast Market Size by Country
10.7.9.1 Brazil
10.7.9.2 Argentina
10.7.9.3 Rest of SA
Chapter 11 Analyst Viewpoint and Conclusion
11.1 Recommendations and Concluding Analysis
11.2 Potential Market Strategies
Chapter 12 Research Methodology
12.1 Research Process
12.2 Primary Research
12.3 Secondary Research
Q1: What would be the forecast period in the Fish Vaccine Market research report?
A1: The forecast period in the Fish Vaccine Market research report is 2024-2032.
Q2: Who are the key players in the Fish Vaccine Market?
A2: Merck Animal Health (United States), Zoetis Inc. (United States), Elanco Animal Health (United States), Phibro Animal Health Corporation (United States), HIPRA (Spain), Virbac (France), Kyoritsu Seiyaku Corporation (Japan), Tecnovax (Argentina), Veterquimica S.A. (Chile), FishVet Group (United Kingdom). and Other Major Players.
Q3: What are the segments of the Fish Vaccine Market?
A3: The Fish Vaccine Market is segmented into by Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines), By Fish Type (Salmon, Tilapia, Trout, Carp, Catfish, Sea Bass, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Immersion Vaccines), By Application (Bacterial Infections, Viral Infections, Parasitic Infections), End-User (Aquaculture Farms, Veterinary Clinics, Research Institutes). By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Q4: What is the Fish Vaccine Market?
A4: The Fish Vaccine Market is expected to go niche to offer vaccinations for fish species against diseases resulting from bacteria, viruses and parasite. These vaccines are vital in fish farming to boost fish health, reduce mortality rate thereby improving yields and new solutions provided to the fish farming market. Vaccination of fishes prevent outbreak of diseases and so prevent the use of antibiotics and chemicals that have capability of polluting the environment in fish farming.
Q5: How big is the Fish Vaccine Market?
A5: Fish Vaccine Market Size is Valued at USD 408.20 Million in 2023, and is Projected to Reach USD 706.64 Million by 2032, Growing at a CAGR of 7.10% From 2024-2032.
How to buy a report from Megatrends.jp
On the product page, select the license you want: Single User License or Enterprise License.
Select the report language:
- English Report
- English Report + Japanese Translation
Click the Buy Now button.
You’ll be redirected to the checkout page. Enter your company and payment details.
Click Place Order to complete your purchase.
Confirmation: You’ll receive an order confirmation email. Our team will then follow up with your report delivery.
If you have questions, fill out the contact form below or email us at sales1@megatrends.jp.
Thank you for choosing Megatrends.jp!
Related products
